A scientific study to design and implement a contingency management (CM) program, and to evaluate its effectiveness in promoting abstinence and treatment adherence among individuals with opioid use disorder, as well as to explore its potential for broader implementation in clinical settings.
Be 18 years of age or older
Have a diagnosis of a substance use disorder (SUD) according to DSM-5 criteria
Be able to understand and provide informed consent
Be willing to comply with study procedures, including regular drug screening and attendance tracking
Have a severe cognitive impairment or active psychosis that interferes with participation
Currently experiencing a medical condition that would make participation unsafe
Single group
contingency management
BehavioralParticipants with opioid use disorder admitted to the inpatient addiction management unit will receive a contingency management (CM) program as a behavioral intervention. The program consists of providing positive reinforcement (small rewards or incentives) contingent upon objective evidence of desired behaviors, primarily drug abstinence verified by urine toxicology screening. The intervention will be delivered throughout the inpatient stay (approximately two weeks). Participants' adherence and abstinence will be monitored, and rewards will be adjusted based on performance.
Relapse Risk Assessment: Assessed using the Advance Warning of Relapse (AWARE) Questionnaire administered at program entry and exit. Changes in AWARE scores will indicate changes in relapse risk and warning signs.
Proportion of opioid-negative urine drug screens during inpatient stay and at 3-month follow-up
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
